Ambalal Sarabhai Enterprises Falls to 52-Week Low of Rs.27.8 Amidst Market Pressure

Dec 02 2025 12:44 PM IST
share
Share Via
Ambalal Sarabhai Enterprises has reached a new 52-week low of Rs.27.8, marking a significant decline in its stock price amid broader market fluctuations and sectoral underperformance. The stock's current position reflects ongoing challenges within the Pharmaceuticals & Biotechnology sector, contrasting with the broader market's relative stability.



Stock Performance and Market Context


On 2 December 2025, Ambalal Sarabhai Enterprises recorded a day change of -2.59%, underperforming its sector by 2.36%. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. This contrasts with the Sensex, which opened 316.39 points lower but remains above its 50-day moving average and is only 1.03% away from its 52-week high of 86,159.02, indicating a more bullish stance for the broader market.



Over the past year, Ambalal Sarabhai Enterprises has delivered a return of -52.51%, significantly lagging behind the Sensex's 6.27% gain over the same period. The stock's 52-week high was Rs.68, highlighting the extent of the decline to its current low.



Financial Metrics and Long-Term Trends


The company’s long-term financial indicators reveal subdued performance. The average Return on Capital Employed (ROCE) stands at 4.55%, reflecting limited efficiency in generating returns from capital investments. Net sales have grown at an annual rate of 7.00% over the last five years, indicating modest expansion but insufficient to drive significant shareholder value.



Recent quarterly results show a Profit Before Tax (PBT) of Rs.-1.66 crore, representing a decline of 548.6% compared to the previous four-quarter average. Similarly, the Profit After Tax (PAT) for the quarter was Rs.-0.56 crore, down 111.3% relative to the prior four-quarter average. Operating cash flow for the year is reported at Rs.-17.62 crore, marking the lowest level in recent periods and suggesting cash generation pressures.




Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!



  • - Clear entry/exit targets

  • - Target price revealed

  • - Detailed report available


View Target Price Report →




Comparative Valuation and Shareholding


Despite the subdued financial performance, Ambalal Sarabhai Enterprises exhibits an attractive valuation metric with an Enterprise Value to Capital Employed ratio of 1.4. The company’s ROCE of 1.5 in the recent period suggests a valuation discount relative to its peers’ historical averages. The Price/Earnings to Growth (PEG) ratio stands at 0.5, reflecting the relationship between earnings growth and valuation.



Majority shareholding is held by non-institutional investors, which may influence trading patterns and liquidity considerations. The stock’s underperformance extends beyond the last year, with returns below the BSE500 index over one year, three years, and the last three months, indicating a persistent trend of relative weakness.



Sector and Market Dynamics


The Pharmaceuticals & Biotechnology sector, in which Ambalal Sarabhai Enterprises operates, has faced mixed performance in recent sessions. While the Sensex remains close to its 52-week high and trades above key moving averages, Ambalal Sarabhai’s stock price trajectory diverges, reflecting company-specific factors rather than sector-wide trends.



Market participants have noted the stock’s consistent trading below all major moving averages, which often signals a lack of upward momentum in the near term. The gap between the stock’s current price and its 52-week high of Rs.68 underscores the scale of the price adjustment over the past year.




Is Ambalal Sarabhai Enterprises your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • - Better alternatives suggested

  • - Cross-sector comparison

  • - Portfolio optimization tool


Find Better Alternatives →




Summary of Key Financial Indicators


Ambalal Sarabhai Enterprises’ financial data over recent periods highlights several areas of concern. The negative operating cash flow of Rs.-17.62 crore for the year indicates cash utilisation beyond operational inflows. The sharp declines in quarterly PBT and PAT figures further illustrate challenges in profitability. Meanwhile, the modest annual net sales growth rate of 7.00% over five years contrasts with the significant stock price decline, suggesting market valuation adjustments beyond sales expansion.



The stock’s current trading level at Rs.27.8 represents a substantial reduction from its 52-week high, reflecting a combination of financial performance and market sentiment. The company’s valuation metrics, including the Enterprise Value to Capital Employed ratio and PEG ratio, suggest that the stock is priced at a discount relative to historical peer averages.



Market Outlook and Broader Implications


While the broader market, as represented by the Sensex, maintains a relatively positive technical stance, Ambalal Sarabhai Enterprises’ stock price movement indicates a divergence that may be attributed to company-specific financial results and valuation considerations. The stock’s position below all major moving averages and its 52-week low price point highlight the challenges faced in regaining upward momentum.



Investors and market watchers will note the contrast between the company’s financial indicators and the broader market’s performance, underscoring the importance of analysing individual stock fundamentals alongside sector and market trends.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News